We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
-7.4%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$28.5B
AUM Growth
-$3.35B
Cap. Flow
-$163M
Cap. Flow %
-0.57%
Top 10 Hldgs %
24.38%
Holding
2,057
New
95
Increased
667
Reduced
873
Closed
147

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Healthcare 19.05%
3 Financials 11.51%
4 Industrials 10.68%
5 Consumer Discretionary 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIVB icon
826
Civista Bancshares
CIVB
$595M
$1.28M ﹤0.01%
53,300
-10,000
-16% -$243K
MFC icon
827
Manulife Financial
MFC
$72.9B
$1.27M ﹤0.01%
59,670
-9,627
-14% -$197K
RPM icon
828
RPM International
RPM
$14.5B
$1.27M ﹤0.01%
15,632
-529
-3% -$45.4K
SCHB icon
829
Schwab US Broad Market ETF
SCHB
$45.2B
$1.27M ﹤0.01%
71,505
-2,637
-4% -$46.3K
TOTL icon
830
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.01B
$1.27M ﹤0.01%
28,327
+8,840
+45% +$406K
GPC icon
831
Genuine Parts
GPC
$18.7B
$1.26M ﹤0.01%
10,036
-152
-1% -$19.7K
ACWV icon
832
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
$1.26M ﹤0.01%
11,989
+300
+3% +$30.9K
COR icon
833
Cencora
COR
$59.2B
$1.26M ﹤0.01%
8,124
+899
+12% +$127K
APAM icon
834
Artisan Partners
APAM
$3.03B
$1.25M ﹤0.01%
31,884
+22,101
+226% +$898K
NKTR icon
835
Nektar Therapeutics
NKTR
$2.57B
$1.25M ﹤0.01%
15,469
-21,083
-58% -$3.12M
OLO
836
DELISTED
Olo Inc
OLO
$1.25M ﹤0.01%
94,288
-1,989
-2% -$30.8K
FVD icon
837
First Trust Value Line Dividend Fund
FVD
$8.4B
$1.25M ﹤0.01%
29,421
FDS icon
838
Factset
FDS
$10.2B
$1.24M ﹤0.01%
2,864
-294
-9% -$124K
SYNH
839
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.24M ﹤0.01%
15,259
-5,064
-25% -$428K
HURN icon
840
Huron Consulting
HURN
$2.47B
$1.22M ﹤0.01%
26,725
-945
-3% -$43.6K
IEF icon
841
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$1.22M ﹤0.01%
11,369
+144
+1% +$16K
WH icon
842
Wyndham Hotels & Resorts
WH
$5.51B
$1.22M ﹤0.01%
14,432
-64
-0.4% -$5.45K
PFGC icon
843
Performance Food Group
PFGC
$16.4B
$1.22M ﹤0.01%
23,987
+7,186
+43% +$352K
LGTY
844
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.22M ﹤0.01%
58,389
-1,315
-2% -$29.1K
BNY
845
Bank of New York Mellon
BNY
$110B
$1.21M ﹤0.01%
24,436
-3,295
-12% -$187K
IPG
846
DELISTED
Interpublic Group of Companies
IPG
$1.21M ﹤0.01%
34,184
-3,344
-9% -$121K
KAI icon
847
Kadant
KAI
$3.91B
$1.21M ﹤0.01%
6,231
-367
-6% -$75.1K
VFC icon
848
VF Corp
VFC
$5.79B
$1.21M ﹤0.01%
21,218
-31,296
-60% -$1.94M
FTCS icon
849
First Trust Capital Strength ETF
FTCS
$8.02B
$1.2M ﹤0.01%
15,343
CPAY icon
850
Corpay
CPAY
$27.9B
$1.2M ﹤0.01%
4,810
-71
-1% -$16.8K

Similar funds

William Blair & Company's Q1 2022 Portfolio in Review

As of Q1 2022, William Blair & Company held 2,057 positions worth $28.5B, down 11% from $31.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

William Blair & Company's Q1 2022 filing shows 95 new, 667 increased, 873 reduced and 147 closed positions. Its largest new stake was Apollo Global Management: 145,513 shares worth $9.02M. The largest sale was IHS Markit Ltd. Common Shares, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q1 2022 buy was Apollo Global Management: 145,513 shares worth $9.02M.
  • William Blair & Company added most to Airbnb in Q1 2022, an estimated $71.5M increase.
  • William Blair & Company's biggest Q1 2022 reduction was CarMax, cutting an estimated $61.4M.
  • William Blair & Company fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $77.7M.
  • William Blair & Company's ten largest holdings make up 24% of its $28.5B portfolio in Q1 2022.
  • William Blair & Company opened 95 new positions and closed 147 in Q1 2022.
  • William Blair & Company's portfolio value fell 11% quarter-over-quarter to $28.5B.

Based on William Blair & Company's 13F filing for Q1 2022, filed 13 May 2022.